Agnieszka Zebrowska
Lodz, LD 90647, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Dipeptidyl peptidase-4 inhibitor-associated mucous membrane pemphigoid leading to severe vision loss treated with rituximab.
Journal: Polish archives of internal medicine
Published: June 29, 2026
A Multicenter Analysis of Patients with Bullous Pemphigoid: Clinical Characteristics and Insights into Drug-Associated Disease.
Journal: International journal of molecular sciences
Published: May 19, 2026
Bullous Pemphigoid Following Total Knee Arthroplasty: A Case Report.
Journal: JBJS case connector
Published: February 12, 2026
The Spectrum of Cutaneous Manifestations in Dermatomyositis: A Comprehensive Review.
Journal: Journal of clinical medicine
Published: February 01, 2026
The Dynamics of Blood-Count-Derived Inflammatory Indices in the Course of Systemic Treatment for Psoriasis: A Single Center Study.
Journal: International journal of molecular sciences
Published: December 29, 2025
Adult-Onset Hypopigmented Mycosis Fungoides: A Systematic Review of Clinicopathologic, Immunophenotypic, and Therapeutic Characteristics.
Journal: Cancers
Published: December 19, 2025
The Role of Accessible Hematological Markers in Bullous Pemphigoid: A Systematic Review.
Journal: International journal of molecular sciences
Published: November 21, 2025
Blood-Count-Derived Inflammatory Biomarkers and Characterization of Super-Responder Profile in Psoriatic Patients Receiving Biological Treatment: A Single-Center Study.
Journal: International journal of molecular sciences
Published: September 14, 2025
Rapidly Progressing CD8-negative Hypopigmented Mycosis Fungoides in Adult Caucasian Male with Good Response to Mogamulizumab.
Journal: Acta dermato-venereologica
Published: May 23, 2025
A phase 3, randomized, double-blind, active-controlled clinical study to compare BAT2206, a ustekinumab biosimilar, with ustekinumab reference product in patients with moderate-to-severe psoriasis: Treatment period 2 results (post Week 28 to Week 52).
Journal: Journal of the American Academy of Dermatology
Published: April 24, 2025
The Relationship Between Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune-Inflammation Index Markers and Response to Biological Therapy in Patients with Psoriasis.
Journal: International journal of molecular sciences
Published: March 22, 2025
Molecular Link Between Psoriasis and Depression-Update on Pathophysiology.
Journal: International journal of molecular sciences
Published: February 11, 2025
Last Updated: 09/26/2026